Archive

  • Dai-ichi Life puts $180m in singularly fishy investment

    16 February 2021

  • Dai-ichi Life invests JPY 100m in Japanese solar power start-up

    15 February 2021

  • Dai-ichi Life invests AUD 125m into health bond for COVID-19 vaccines

    01 February 2021

    Asian Development Bank bond focused on support and supply of vaccines

  • Dai-ichi Life invests JPY 100m in heart medicine developer

    05 January 2021

    Aging population means more people living with chronic heart diseases

  • Dai-ichi Life invests JPY 3bn into COVID relief for Africa

    21 December 2020

    Funding for purchasing masks, repairing medical equipment, and supporting companies

  • Japanese life insurers' capitalisation improved in H1 2020 but still weak to market shocks

    04 December 2020

    Movement away from domestic bonds to foreign becoming increasingly transparent

  • Dai-ichi Life invests in BlackRock renewable infrastructure fund

    15 October 2020

    Fund focuses on solar, wind and other renewable power generation facilities

  • Dai-ich Life joins SASB's advisory group

    31 July 2020

    First Japanese asset owner to join the organisation

  • Dai-ichi subsidiaries invests $70m in plastic waste reduction corporate bond

    08 July 2020

    Described as first corporate bond linked to reducing plastic waste

  • Insurers' social investing takes the spotlight in battle against COVID-19

    18 May 2020

    If the pandemic has any silver lining, it is in boosting the prominence of the social aspect of environmental, social and governance (ESG) investing. David Walker investigates this 'elevation', and whether it will outlast the virus it is being rallied to combat.